DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Accordingly, muscle biopsy showed primitive muscle damage, and immunofluorescence analysis revealed a significant reduction in dystrophin, compatible with dystrophinopathy, which was confirmed by molecular analysis.